🎯 check Ipatasertib (GDC-0068) product page
Ipatasertib (GDC-0068) is a potent, ATP-competitive AKT inhibitor. It affects PI3K/AKT/mTOR signaling pathways by binding to the AKT ATP-binding pocket, effectively inhibiting tumor cell proliferation, migration, and invasion, and promoting apoptosis.